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A variety of N-terminal heterocyclic constituents of protease inhibitors have been shown to interact with key residues in the S 3 hydrophobic pocket of cysteine proteases (Figure1). A series of quinoline derivatives 1 were designed based on the expectation that the formation of additional hydrogen bonds might be possible via an interaction between the -NH in 1 and calpain residues; 6 the P 3 morpholine urea 2 creates a favorable electrostatic interaction with the sidechain ammonium group of Lys 64 in the S 3 pocket of Cathepsin S; 7 and the extended P 3 methylpiperazine-thiazolebenzamide 3 is sufficiently close to form an ionic interaction to Asp 61 in the S 3 pocket of Cathepsin K. 8 In this paper we extend this methodology by designing protease inhibitors with N-terminal heterocyclic moieties that are capable of preferentially binding o-CAPN2 over o-CAPN1, resulting in isoform-selective calpain inhibitors. Finally aldehydes 11-13 were prepared as described in Scheme 3. The substituted 2-pyrrole carboxylic acid precursors 27-29 were synthesised using standard literature procedures. 19, 20 5-Formyl-N-methylpyrrole-2-carboxylic acid 27 was synthesized via alkylation of 2-pyrrole carboxylic acid using methyl iodide and NaOH followed by base-mediated ester hydrolysis. 19 5-Methylpyrrole-2-carboxylate 28 was synthesized from the reaction of diethyl acetamidomalonate and 1,4-dichloro-2-butyne using NaOEt as a base in refluxing EtOH under the method developed by Curran and Keaney followed by ester hydrolysis. 20 5-Methoxy carbonyl-2-pyrrole carboxylic acid 29 was synthesized via KMnO 4 oxidation of the corresponding 5-formyl ester in methanol. 19 The precursors 27-29 were then reacted with key intermediate 15 to yield the alcohols 30-32 that were subsequently oxidized to give the corresponding aldehydes 11-13 (Scheme 3). 
Ovine calpain sequence
The amino acid sequences of catalytic subunits of o-CAPN1 and o-CAPN2 were determined from their cDNA sequences (Genebank accession numbers XXXXXXXX and EU161096 respectively). o-CAPN2
had two alleles with a G replaced by T at 741 and C replaced by a T at 1539. However neither of these altered the amino acid sequence. The ovine calpains were more homologous to human calpains (h-CAPN1 21 and h-CAPN2 22 ) than the rat calpains (r-CAPN1 23 and r-CAPN2 34 ) sequences. The o-CAPN1 amino acid sequence was 95% homologous with the h-CAPN1, considerably closer than the 89% homology of r-CAPN1 to h-CAPN1. The calpain 2 large subunit was 95% homologous between ovine and human compared with 94% for rat and human. Of the 35 amino acid which were different between o-CAPN2 and h-CAPN2, 18 were conservative substitutions with similar amino acids and the changes were clustered in non-essential regions of the protein. The homology between ovine calpain isoforms is similar to that in other species, with o-CAPN2 62% homologous to o-CAPN1. o-CAPN2 is also 62 % homologous to h-CAPN1.
Alignment of selected residues in the catalytic domain of ovine, human and rat calpain highlight the greater homology between ovine calpains and h-CAPN1 compared to r-CAPN1 ( Figure 2 ). Within these sections there are 11 amino acids different between h-CAPN1 and r-CAPN1 and only 2 between h-CAPN1 and o-CAPN1. There are 9 differences between h-CAPN1 and o-CAPN2. However; only 2 of these differences (Ser 209 corresponds to Ala 199 and Met 260 corresponds to Ser 250 in o-CAPN2) in occur in close proximity to the active site. 
Biological activity
The compounds 4-13 were assayed against o-CAPN1 and o-CAPN2 (purified from ovine lung tissue) using a fluorescence-based assay to determine in vitro potency and selectivity. 25 The assay results are summarized in 
Construction of in-silico ovine calpain homology models
Molecular modeling was used to rationalize the observed SAR of compounds 4-13. Novel in-silico ovine calpain homology models were constructed using the o-CAPN1 and o-CAPN2 sequences and h-CAPN1 X-ray crystal structure data available from the Protein Data Bank (PDB code 1-ZCM). 28 The most appropriate calpain X-ray crystal structure information was required to build accurate in-silico ovine calpain models. A limited number of X-ray crystal structures of the active catalytic domains of calpain 1 and 2 have been published. The majority of these crystal structures have been obtained by Davies et al using a rat calpain 1 (r-CAPN1) construct. 29 Unfortunately, useful structural information is not available for the rat calpain 2 (r-CAPN2) construct due to an instability in helix α7, which results in intrinsic inactivation. 30 Only two h-CAPN1 construct crystal structures have been published. 31, 28 Sequence alignment of selected residues of h-CAPN1, 21 r-CAPN1, 23 and o-CAPN1 as well as o-CAPN2
clearly shows that a high degree of homology exists within the residues that form the active site cleft of ovine calpains and h-CAPN1 ( Figure 2 ). Therefore, the h-CAPN1 X-ray crystal structure (1-ZCM) was used as the structural basis for the o-CAPN1 homology model.
A similar strategy was employed to build the o-CAPN2 homology model. However, the only human calpain 2 (h-CAPN2) crystal structure available is in an inactivated form. 31 Therefore despite a number of differences in the amino acid sequence of h-CAPN1 and o-CAPN2 (Figure 2) , it was decided to build the in silico o-CAPN2 homology model from the h-CAPN1 X-ray crystal structure (1-ZCM) 28 as this is the most accurate X-ray crystal structure available and is thus most likely to rationalize the observed SAR of compounds 4-13.
Molecular modeling and SAR discussion
The h-CAPN1 X-ray crystal structure, 1-ZCM, was virtually mutated around the active site cleft to (Figure 3a and 3b) . 16 In sharp contrast, the more selective inhibitors (7 and 9) appear to bind to the two homology models in different conformations. For example 5-formyl pyrrole 9 binds to the o-CAPN1 homology model in a typical β-strand binding conformation ( Figure 3c ) whereas a unique shunted conformation is observed for the binding of 9 to the o-CAPN2 homology model (Figure 3d ).
This unique shunted conformation places the aldehyde in closer proximity to the active site cysteine 
In vitro lens culture assay
Over-activation of calpain 2 has been linked to the development of cortical cataract and therefore the o-CAPN2 selective inhibitor 9 was assayed in an in vitro lens culture system. The ability of inhibitor 9
to retard calpain-induced cell damage in ovine lenses was studied. We have previously reported a detailed method for this assay. 11 Briefly, inhibitor 9 (0.8 μM) was added to one lens of a pair of sheep lenses in culture media. After 2 hours incubation, calcium was added to all lenses to activate the constituent calpains and hence induce cataract formation. After 24 h all lenses were photographed and the opacity graded; see Figure 3 for representative examples. Lenses treated with calcium only (for example lens 1 in Figure 6 ) clearly showed the opacity associated with cataract formation; however, lenses treated with calcium in the presence of 9 (e.g. lens 2) essentially remained transparent, as revealed by the reference grid placed behind each lens. The loss of transparency was significantly reduced by 9 (p <0.005) in a paired t-test.
Lens 1 Lens 2
Mean opacification grading score (± sd) 45.1 ± 2.9 27.9 ± 5.5 Figure 3 . Calcium induced cataract in ovine lenses. The scores represent the average result using three lens pairs. Opacification scores of 100 = full opacity whereas a score of 1 = clear and transparent.
Conclusion
A range of N-terminal hetrocyclic-dipeptide aldehydes 4-13, designed to interact with the S3 binding pocket of calpain, were prepared and evaluated as anti-cataract agents. The efficacy of the compounds was tested using ovine calpain and an ovine lens culture assay as this has been shown to be an effective model for human cataract.
Compounds 4-13 are potent calpain inhibitors (all IC 50 values below 1 μM) that show varying degrees of isoform-selectivity. Compounds containing a 5-formyl substituted heterocyclic moiety (compounds 7 and 9) gave the greatest degree of isoform-selectivity. The 5-formyl pyrrole 9 was highly active against o-CAPN2 (IC 50 25 nM) and exhibited greater than 11-fold selectivity for o-CAPN2 over o-CAPN1. In contrast, other well documented dipeptidyl aldehyde calpain inhibitors such as SJA6017 and MDL28170 display selectivity for calpain 1 over calpain 2.
The amino acid sequences of catalytic subunits of o-CAPN1 and o-CAPN2 were determined from their cDNA sequences and had 95% homology to the human isoforms. In silico homology models were generated from the o-CAPN1 and o-CAPN2 sequences and h-CAPN1 X-ray crystal structure data. The models were used to rationalize the observed SAR of compounds 4-13. In particular, two distinct binding conformations were revealed for the 5-formyl pyrrole 9 that might explain the observed greater than 11-fold selectivity of this compound for o-CAPN2 over o-CAPN1. o-CAPN2 selective inhibitor 9
was assessed in an in vitro lens culture assay and shown to successfully retard the formation of a calcium-induced cataract in ovine lenses. Further development of 5-formyl pyrrole 9 is ongoing and its suitability for use as an anti-cataract agent will be reported in a future publication.
Experimental

Chemistry
Proton NMR spectra were acquired on a Varian Inova 500 spectrometer operating at 500 MHz unless otherwise stated. Carbon NMR spectra were obtained on a Varian Unity XL 300MHz Fourier 1-((S)-1-hydroxymethyl-3 
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Sequencing of ovine calpains
RNA was isolated from ovine muscle tissue using an RNeasy® Mini Kit (Qiagen GmbH, Hilden, Germany) as per the manufacturer's instructions.
Calpain 1 cDNA was synthesised following the maufacturer's protocol using non-specific primers and The consensus coding sequences for ovine calpain 1 ( bp) and calpain 2 (2103bp) were constructed from sequence data derived from PCRs performed on several non-related animals and submitted to GenBank (accession number XXXXXXXX and EU161096 respectively).
Enzyme assays
o-CAPN1 and o-CAPN2, partially purified from sheep lung by hydrophobic and ion-exchange chromatography, was diluted in a mixture containing 20 mM MOPS, 2 mM EGTA, 2 mM EDTA and 
Lens culture
The EMEM culture medium for normal culture (EMEM, pH 7. . Calpain inhibitors were solubilised in DMSO to give a final concentration of DMSO in EMEM of less than 0.05%. Adequate amounts of DMSO were added to the medium containing 5 mM Ca 2+ so there was no effect attributed by DMSO. Groups of ovine eye globes from 9-12 month old lambs, were collected from a local slaughterhouse immediately after slaughter and delivered to the laboratory for lens dissection. Pairs of lenses from the eyes of each animal were kept together. Three pairs of lenses were dissected within 2 h of death of the animal using the posterior approach. The intact lenses were immediately placed in a sterile culture dish containing 10 mL of culture medium per lens. The entire lens was submerged with its anterior epithelium facing upward in the medium, which had been pre-incubated at 37 °C with 5% CO 2 for 48 h in a sterilised chamber. One of each of the paired lenses, was pre-incubated with 6 (0.8 μM) in EMEM for 2.5 h, whilst the other was cultured in EMEM only. Both lenses were then exposed to Ca 2+ in EMEM to give a final concentration 
Molecular Modeling
All molecular modeling experiments were conducted with the Schrödinger suite 2005. Conformational searches on 4-13 were carried out with MacroModel 9.1, generating an ensemble of low energy conformers to establish suitable starting conformations of each compound for the docking. 31 The searches were conducted with the MCMM method using a GB/SA water model and the OPLS2001 force field, with 3000 steps for the conformational search and up to 5000 iterations for the minimization of each generated structure. The minimization was stopped with the default gradient convergence threshold of d = 0.05 kJ/(mol*Å). The default Polak-Ribiere Conjugate Gradient method was used for all minimizations. The crystal structure of human mini calpain 1 (PDB code 1-ZCM) 28 was prepared using the protein preparation facility in GLIDE 4.0 followed by mutation of Ser115->Cys115, deprotonation of Cys115, and protonation of His272. 32 The in-silico ovine homology models were created by the virtual mutation of the appropriate residues around the active site cleft. These structures were minimized using the OPLS2005 force field with a GB/SA water model over 500 iterations. All residues within a 5Å distance to the calcium ions, the calcium ions and the key residues Gly 208 , Gly 271
and Cys 115 (or Gly 198 , Gly 261 and Cys 105 ) of the structures were kept frozen during this minimization.
The centre of the docking grid was defined as the centroid of the residues Cys115, Gly208, and Gly271
and was generated with GLIDE 4.0 using default settings. The centre of the docked ligands was defined 
